Abstract | BACKGROUND: OBJECTIVE: Our goal was to determine whether these reactions are demonstrable in plasma and distinguish them from activation through factor XII. METHODS: Plasma was incubated in polystyrene plates and assayed for kallikrein formation. C1-INH was removed from factor XII-deficient plasma by means of immunoadsorption. RESULTS: CONCLUSIONS:
|
Authors | Kusumam Joseph, Baby G Tholanikunnel, Anette Bygum, Berhane Ghebrehiwet, Allen P Kaplan |
Journal | The Journal of allergy and clinical immunology
(J Allergy Clin Immunol)
Vol. 132
Issue 2
Pg. 470-5
(Aug 2013)
ISSN: 1097-6825 [Electronic] United States |
PMID | 23672780
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. |
Chemical References |
- Complement C1 Inactivator Proteins
- Complement C1 Inhibitor Protein
- HSP90 Heat-Shock Proteins
- Kininogen, High-Molecular-Weight
- SERPING1 protein, human
- Factor XII
- Prekallikrein
- Kallikreins
- Bradykinin
|
Topics |
- Angioedemas, Hereditary
(physiopathology)
- Bradykinin
(metabolism)
- Complement C1 Inactivator Proteins
(metabolism)
- Complement C1 Inhibitor Protein
- Factor XII
(metabolism)
- Female
- HSP90 Heat-Shock Proteins
(metabolism)
- Hereditary Angioedema Types I and II
(physiopathology)
- Humans
- Kallikreins
(metabolism)
- Kininogen, High-Molecular-Weight
(metabolism)
- Male
- Prekallikrein
(metabolism)
|